U.S. Oil and Gas Stock News

Context for United Bankshares after recent moves United Bankshares (UBSI) has drawn fresh attention after recent share price moves, with the stock closing at $41.38. Investors are weighing this level against the bank's fundamentals and recent return profile. See our latest analysis for United Bankshares. While the latest share price of $41.38 comes after a softer 7 day and 30 day share price return, the 90 day share price return of 8.64% and 1 year total shareholder return of 21.98% suggest...

Axon Enterprise (NasdaqGS:AXON) reported strong Q4 results, with management highlighting what it described as industry leading growth in AI powered public safety tools. The company saw rapid uptake of its generative AI report writing tool, Draft One, among law enforcement customers. Axon expanded further into emergency communications through acquisitions that broaden its public safety technology suite. Recent insider selling by senior executives, including the COO and CFO, has drawn...

Key business snapshot for Viking Holdings Viking Holdings (VIK) has been drawing attention after recent trading, with shares last closing at $75.28. For investors, the immediate reference points are its recent returns and the scale of its current operations. See our latest analysis for Viking Holdings. Recent trading has been choppy, with a 1 day share price return of a 1.49% decline and a 7 day share price return of a 4.93% decline. However, a 90 day share price return of 11.34% and a 1 year...

Quanta Services recently reported fourth‑quarter 2025 results and full‑year figures, with sales of US$7,841.95 million for the quarter and US$28.48 billion for the year, alongside net income of US$315.45 million for the quarter and US$1.03 billion for the year. The company also issued 2026 guidance calling for revenues of about US$33.25–US$33.75 billion and adjusted diluted EPS of US$12.65–US$13.35, underpinned by recent acquisitions and strength in its Electric division. We’ll now examine...

In recent days, Jefferies upgraded Fluence Energy from Hold to Buy, pointing to improved U.S. market conditions and a restated fiscal 2026 revenue and adjusted EBITDA outlook. Fluence’s record project backlog of over US$5.50 billion, supported by almost US$750 million in new quarterly orders, underscores mounting demand from data centers, utilities, and industrial customers. We’ll now examine how Jefferies’ upgrade, centered on Fluence’s record backlog strength, may influence the company’s...

Urban Outfitters (URBN) is back in focus after reporting fourth quarter and full year results, with higher sales in both periods, a mixed picture on net income, and a completed multi year share repurchase program. See our latest analysis for Urban Outfitters. The latest earnings release and completed buyback come after a weaker 30-day share price return of a 7.85% decline and a 90-day share price return of an 11.65% decline. However, the 1-year total shareholder return of 16.67% and 3-year...

Super Group (SGHC) stock is drawing fresh attention after the company reported strong adjusted EBITDA growth and margin expansion in its latest earnings report, along with higher 2026 revenue guidance and a richer dividend program. See our latest analysis for Super Group (SGHC). The latest earnings, higher 2026 revenue guidance and the richer dividend program appear to be supporting renewed momentum, with the 30 day share price return of 23.35% and a 1 year total shareholder return of 66.64%...

In late February 2026, Day One Biopharmaceuticals reported fourth-quarter 2025 revenue of US$53.7 million with a US$21.3 million net loss, and the European regulator’s committee issued a positive opinion supporting conditional marketing authorization of OJEMDA for relapsed or refractory BRAF‑altered pediatric low‑grade glioma. This combination of improving quarterly losses and progress toward conditional European approval for OJEMDA highlights both growing commercial traction and expanding...

AMD and Meta agreed to a multi year partnership for up to 6 gigawatts of AI data center processing, valued at over $100b. The deal includes joint work on new GPU architectures, custom silicon, systems, and software for Meta's future AI platforms. Meta may receive a performance based equity stake in NasdaqGS:AMD as part of the agreement. AMD expanded U.S. manufacturing for advanced AI accelerators and introduced new Ryzen AI 400 Series desktop chips. NasdaqGS:AMD is moving deeper into large...

In recent weeks, Capital One reported very large year-on-year revenue growth that beat analyst expectations, but missed earnings and net interest margin estimates, while facing a new securities-fraud investigation and ongoing integration of Discover and the planned Brex acquisition. These mixed results, combined with regulatory concerns such as potential interest rate caps and insider share sales under a trading plan, highlight how execution, legal risk, and policy shifts could influence...

HCA Healthcare, NYSE:HCA, is preparing for a financial impact linked to expected declines in Affordable Care Act insurance enrollments. The company is adjusting operations to this shift while pursuing AI integration, new emergency care centers, and leadership changes. These moves come as investors weigh the earnings impact projected for 2026 against the company’s longer term strategic initiatives. HCA Healthcare enters this period of change with its shares at $544.41, after a 71.6% return...

In February 2026, Texas Capital Bancshares completed a US$400,000,000 fixed-to-floating rate senior unsecured note offering due 2032, while director Robert W. Stallings bought 40,000 Series B preferred depositary shares and the bank reaffirmed a cash dividend on those shares. Institutional investors such as JPMorgan Chase and Quantbot Technologies expanded their positions as Texas Capital also earned a Best Bank recommendation for middle market clients. We’ll now examine how this combination...

TG Therapeutics and Precision BioSciences reported a new clinical milestone for azercabtagene zapreleucel in progressive multiple sclerosis. The milestone is tied to an exclusive worldwide license for autoimmune diseases between the two companies. The progress with azer cel adds a new autoimmune program alongside TG Therapeutics' existing BRIUMVI franchise. TG Therapeutics, trading on NasdaqCM:TGTX, is drawing fresh attention as it builds out its autoimmune pipeline beyond BRIUMVI. The...

Cigna Group (NYSE:CI) announced a CEO succession, with longtime chief executive David M. Cordani set to retire. Brian Evanko, currently a senior leader within the company, will assume the CEO role. The transition marks a significant leadership change at the top of the health services provider. Cigna Group operates as a global health services company, with a focus on medical benefits, pharmacy benefits, and related services for employers, governments, and individuals. Leadership shifts at a...

Amgen (NasdaqGS:AMGN) and Kyowa Kirin have decided to discontinue clinical development of rocatinlimab. The decision follows emerging safety concerns identified during ongoing clinical trials. All active studies of rocatinlimab are being halted, affecting programs in dermatology and immunology. For you as an investor, this matters because rocatinlimab had been part of Amgen's push into immunology and dermatology, areas that attract significant R&D interest across large biopharma companies...

What investors can see in Exact Sciences today Exact Sciences (EXAS) continues to attract attention as a cancer diagnostics business with US$3,246.99m in annual revenue, a reported net loss of US$207.949m, and a recent share price around US$103.50. See our latest analysis for Exact Sciences. At around US$103.50, Exact Sciences has seen relatively steady short term share price moves, while the 1 year total shareholder return of 117.30% contrasts with a 5 year total shareholder return decline...

Robinhood Markets (NasdaqGS:HOOD) is rolling out new features aimed at higher net-worth customers, including plans for broader wealth management tools beyond stock and crypto trading. The company is hosting a high profile product launch event to showcase services that push its platform toward a more comprehensive financial app. ARK Invest has recently made large purchases of Robinhood shares, adding institutional attention to the stock. Robinhood Markets is trying to reposition itself with...

Colgate-Palmolive stock snapshot and recent performance Colgate-Palmolive (CL) has drawn investor attention recently, with the share price at $95.28 and returns that include a 3.7% gain over the past month and 22.8% over the past 3 months. For a global consumer products group with two main segments (Oral, Personal and Home Care, and Pet Nutrition), these figures give you a reference point for how the stock has behaved before you look more closely at fundamentals. See our latest analysis for...

If you are wondering whether Compañía de Minas BuenaventuraA’s share price still reflects its underlying worth, starting with a clear look at valuation can help you frame that question properly. The stock recently closed at US$39.34, with returns of a 1.7% decline over 7 days, 15.5% over 30 days, 37.6% year to date, 196.6% over 1 year and 408.4% over 3 years, which can change how investors think about both upside and risk. Recent news coverage around Compañía de Minas BuenaventuraA has...

In February 2026, Procore Technologies and United Rentals announced a new partnership and telematics integration that lets shared customers feed United Rentals’ rental equipment data directly into Procore’s Resource Management platform to improve visibility and simplify equipment management across jobsites. This integration creates a unified view of owned and rented equipment alongside labor and materials, enabling AI-driven recommendations that can help contractors improve productivity,...

If you are wondering whether PDD Holdings is offering good value at its current price, you are not alone. This article is built to help you make sense of what the market might be pricing in. The stock recently closed at US$101.19, with returns of a 5.3% decline over 7 days, a 2.2% decline over 30 days, a 12.6% decline year to date, and a 15.8% decline over 1 year. The 3 year and 5 year returns sit at an 8.8% decline and a 31.7% decline respectively. Recent coverage has focused on PDD...

If you are wondering whether Rivian Automotive's share price matches what you are actually getting for your money, this article will walk through how its current market value stacks up against a few different valuation checks. Rivian's stock most recently closed at US$14.92, with returns of 3.3% over the last 30 days, a 30.6% gain over the past year, and declines of 2.2% over 7 days and 23.1% year to date. Recent headlines around Rivian have focused on its position in the electric vehicle...

Why Firefly Aerospace is on investors’ radar today Firefly Aerospace (FLY) has drawn investor attention after recent share price swings, with the stock up about 2.6% over the past day and roughly 5.2% over the past week. See our latest analysis for Firefly Aerospace. The recent 1-day share price return of 2.6% and 7-day share price return of 5.2% come after a weaker spell, with the 30-day share price return at a 6.4% decline and the year to date share price return at a 9.9% decline. This...

Why AI-driven trading signals are suddenly focusing on Seaboard AI-driven trading systems have recently flagged Seaboard (SEB) for what they view as favorable risk reward setups across multiple timeframes, drawing fresh institutional attention to a stock many retail investors rarely watch. See our latest analysis for Seaboard. While Seaboard’s share price has eased in the last month, with a 1 month share price return decline of 2.33%, the 90 day share price return of 14.20% alongside a 1 year...